CEA Process to Be Improved, but Operational Issues Remain: PhRMA/EFPIA

January 20, 2022
Japan’s FY2022 reform plan for the cost-effectiveness assessment (CEA) scheme includes certain improvements for the operational process, but further issues remain unaddressed, major US and European trade groups stressed on January 19. This view was provided in a joint statement...read more